90 related articles for article (PubMed ID: 2584710)
1. The role of the Ia-invariant chain complex in the posttranslational processing and transport of Ia and invariant chain glycoproteins.
Simonis S; Miller J; Cullen SE
J Immunol; 1989 Dec; 143(11):3619-25. PubMed ID: 2584710
[TBL] [Abstract][Full Text] [Related]
2. Kinetics of Ii synthesis, processing, and turnover in n-butyrate-treated Burkitt's lymphoma cell lines which express or do not express class II antigens and in hairy leukemic cells.
Spiro RC; Sairenji T; Humphreys RE
J Immunol; 1985 May; 134(5):3539-49. PubMed ID: 3856614
[TBL] [Abstract][Full Text] [Related]
3. Murine Ia-associated invariant chain's processing to complex oligosaccharide forms and its dissociation from the I-Ak complex.
Holt GD; Swiedler SJ; Freed JH; Hart GW
J Immunol; 1985 Jul; 135(1):399-407. PubMed ID: 3873494
[TBL] [Abstract][Full Text] [Related]
4. Invariant chain influences post-translational processing of HLA-DR molecules.
Schaiff WT; Hruska KA; Bono C; Shuman S; Schwartz BD
J Immunol; 1991 Jul; 147(2):603-8. PubMed ID: 2071896
[TBL] [Abstract][Full Text] [Related]
5. Expression of invariant chain can cause an allele-dependent increase in the surface expression of MHC class I molecules.
Reber AJ; Turnquist HR; Thomas HJ; Lutz CT; Solheim JC
Immunogenetics; 2002 May; 54(2):74-81. PubMed ID: 12037599
[TBL] [Abstract][Full Text] [Related]
6. Biosynthetic relationships of the chondroitin sulfate proteoglycan with Ia and invariant chain glycoproteins.
Sant AJ; Cullen SE; Schwartz BD
J Immunol; 1985 Jul; 135(1):416-22. PubMed ID: 3858382
[TBL] [Abstract][Full Text] [Related]
7. Characterization of fragments of the murine Ia-associated invariant chain.
Mehringer JH; Harris MR; Kindle CS; McCourt DW; Cullen SE
J Immunol; 1991 Feb; 146(3):920-7. PubMed ID: 1988503
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and expression of MHC class II molecules in the absence of attached invariant chains by recombinant-interferon-gamma-activated bone-marrow-derived macrophages.
Schneider FJ; Opel B; Ballhausen W; Henkes W; Steinlein P; Reske K
Eur J Immunol; 1987 Sep; 17(9):1235-42. PubMed ID: 3115789
[TBL] [Abstract][Full Text] [Related]
9. Assembly and transport properties of invariant chain trimers and HLA-DR-invariant chain complexes.
Lamb CA; Cresswell P
J Immunol; 1992 Jun; 148(11):3478-82. PubMed ID: 1588042
[TBL] [Abstract][Full Text] [Related]
10. Biosynthesis and processing of class II histocompatibility antigens.
Cresswell P; Blum JS; Kelner DN; Marks MS
Crit Rev Immunol; 1987; 7(1):31-53. PubMed ID: 3545672
[TBL] [Abstract][Full Text] [Related]
11. Surface expression of the invariant chain (CD74) is independent of concomitant expression of major histocompatibility complex class II antigens.
Henne C; Schwenk F; Koch N; Möller P
Immunology; 1995 Feb; 84(2):177-82. PubMed ID: 7750992
[TBL] [Abstract][Full Text] [Related]
12. Phosphorylation regulates the delivery of MHC class II invariant chain complexes to antigen processing compartments.
Anderson HA; Roche PA
J Immunol; 1998 May; 160(10):4850-8. PubMed ID: 9590232
[TBL] [Abstract][Full Text] [Related]
13. Peptide binding inhibits protein aggregation of invariant-chain free class II dimers and promotes surface expression of occupied molecules.
Germain RN; Rinker AG
Nature; 1993 Jun; 363(6431):725-8. PubMed ID: 8515815
[TBL] [Abstract][Full Text] [Related]
14. Biosynthesis and glycosylation of the invariant chain associated with HLA-DR antigens.
Machamer CE; Cresswell P
J Immunol; 1982 Dec; 129(6):2564-9. PubMed ID: 6982931
[TBL] [Abstract][Full Text] [Related]
15. Ia antigens and associated invariant chain are induced simultaneously in lines of T-dependent mast cells by recombinant interferon-gamma.
Koch N; Wong GH; Schrader JW
J Immunol; 1984 Mar; 132(3):1361-9. PubMed ID: 6420464
[TBL] [Abstract][Full Text] [Related]
16. Fatty acylation of murine Ia alpha, beta, and invariant chains.
Simonis S; Cullen SE
J Immunol; 1986 Apr; 136(8):2962-7. PubMed ID: 3082975
[TBL] [Abstract][Full Text] [Related]
17. Murine class II (Ia) molecules associate with human invariant chain.
Glimcher LH; Polla BS; Poljak A; Morton CC; McKean DJ
J Immunol; 1987 Mar; 138(5):1519-23. PubMed ID: 3468175
[TBL] [Abstract][Full Text] [Related]
18. A mutant antigen-presenting cell defective in antigen presentation expresses class II MHC molecules with an altered conformation.
Dang LH; Lien LL; Benacerraf B; Rock KL
J Immunol; 1993 May; 150(10):4206-17. PubMed ID: 8482833
[TBL] [Abstract][Full Text] [Related]
19. Structural analysis of invariant chain subsets as a function of their association with MHC class II chains.
Nguyen QV; Reyes VE; Humphreys RE
Arch Biochem Biophys; 1995 Feb; 317(1):128-32. PubMed ID: 7872774
[TBL] [Abstract][Full Text] [Related]
20. Variation in HLA-DM expression influences conversion of MHC class II alpha beta:class II-associated invariant chain peptide complexes to mature peptide-bound class II alpha beta dimers in a normal B cell line.
Ramachandra L; Kovats S; Eastman S; Rudensky AY
J Immunol; 1996 Mar; 156(6):2196 - 2204. PubMed ID: 8690909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
